Preparative Electrophoresis for HDL Particle Size Separation and Intact-Mass Apolipoprotein Proteoform Analysis.


Journal

Journal of proteome research
ISSN: 1535-3907
Titre abrégé: J Proteome Res
Pays: United States
ID NLM: 101128775

Informations de publication

Date de publication:
05 05 2023
Historique:
pmc-release: 05 05 2024
medline: 8 5 2023
pubmed: 14 4 2023
entrez: 13 4 2023
Statut: ppublish

Résumé

The most abundant proteins on high-density lipoproteins (HDLs), apolipoproteins A-I (APOA1) and A-II (APOA2), are determinants of HDL function with 15 and 9 proteoforms (chemical-structure variants), respectively. The relative abundance of these proteoforms in human serum is associated with HDL cholesterol efflux capacity, and cholesterol content. However, the association between proteoform concentrations and HDL size is unknown. We employed a novel native-gel electrophoresis technique, clear native gel-eluted liquid fraction entrapment electrophoresis (CN-GELFrEE) paired with mass spectrometry of intact proteins to investigate this association. Pooled serum was fractionated using acrylamide gels of lengths 8 and 25 cm. Western blotting determined molecular diameter and intact-mass spectrometry determined proteoform profiles of each fraction. The 8- and 25 cm experiments generated 19 and 36 differently sized HDL fractions, respectively. The proteoform distribution varied across size. Fatty-acylated APOA1 proteoforms were associated with larger HDL sizes (Pearson's

Identifiants

pubmed: 37053489
doi: 10.1021/acs.jproteome.2c00804
pmc: PMC10436667
mid: NIHMS1923751
doi:

Substances chimiques

Apolipoproteins 0
Lipoproteins, HDL 0
Apolipoprotein A-I 0
Cholesterol 97C5T2UQ7J
Cholesterol, HDL 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1455-1465

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN268201800003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL133601
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800006I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800007I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800004I
Pays : United States
Organisme : NIGMS NIH HHS
ID : P41 GM108569
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM105538
Pays : United States

Références

J Vis Exp. 2016 Feb 29;(108):53597
pubmed: 26967310
Curr Opin Lipidol. 2019 Feb;30(1):24-29
pubmed: 30531230
Am J Cardiol. 2003 Apr 3;91(7A):12E-17E
pubmed: 12679198
Biomark Med. 2016 Nov;10(11):1197-1207
pubmed: 27673558
J Proteome Res. 2018 Jun 1;17(6):2156-2164
pubmed: 29649363
J Lipid Res. 2017 Mar;58(3):600-606
pubmed: 28049656
Mol Cell Proteomics. 2017 Apr;16(4):680-693
pubmed: 28223350
J Proteome Res. 2010 Oct 1;9(10):5239-49
pubmed: 20718489
Biochemistry. 2007 Jul 17;46(28):8445-50
pubmed: 17580958
Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):870-6
pubmed: 19325143
J Lipid Res. 2017 Jul;58(7):1374-1385
pubmed: 28476857
Curr Opin Lipidol. 2011 Jun;22(3):176-85
pubmed: 21537175
Atherosclerosis. 2002 Feb;160(2):399-406
pubmed: 11849664
Nat Chem Biol. 2018 Jan;14(1):36-41
pubmed: 29131144
Acc Chem Res. 2000 May;33(5):299-306
pubmed: 10813874
J Clin Epidemiol. 1988;41(11):1105-16
pubmed: 3204420
J Clin Lipidol. 2009 Feb;3(1):39-44
pubmed: 21291787
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):156-63
pubmed: 19778948
Physiol Genomics. 2010 Feb 4;40(3):208-15
pubmed: 19903763
Methods Enzymol. 1986;128:181-209
pubmed: 3724502
Anal Chem. 2015 Mar 3;87(5):3032-8
pubmed: 25664979
PLoS One. 2014 Apr 02;9(4):e93552
pubmed: 24695360
Methods Enzymol. 1986;128:417-31
pubmed: 3724517
Diabetes Res Clin Pract. 2011 Sep;93(3):312-3
pubmed: 21820751
Nature. 2011 Oct 30;480(7376):254-8
pubmed: 22037311
J Am Heart Assoc. 2021 Sep 7;10(17):e019890
pubmed: 34472376
Anal Biochem. 1981 Nov 15;118(1):197-203
pubmed: 6175245
Anal Chem. 2014 May 20;86(10):4961-8
pubmed: 24807621
Int J Cancer. 2019 Apr 15;144(8):1877-1887
pubmed: 30259989
EuPA Open Proteom. 2015 Sep;8:40-47
pubmed: 26753126

Auteurs

Cameron Lloyd-Jones (C)

Department of Chemistry, Department of Molecular Biosciences, Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States.

Henrique Dos Santos Seckler (H)

Department of Chemistry, Department of Molecular Biosciences, Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States.

Nicholas DiStefano (N)

Department of Chemistry, Department of Molecular Biosciences, Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States.

Allan Sniderman (A)

Royal Victoria Hospital-McGill University Health Centre, Montreal, Quebec H3A 1W9, Canada.

Phillip D Compton (PD)

Department of Chemistry, Department of Molecular Biosciences, Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States.

Neil L Kelleher (NL)

Department of Chemistry, Department of Molecular Biosciences, Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States.

John T Wilkins (JT)

Departments of Medicine (Cardiology) and Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH